AJH-2947
/ J Mackem
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 17, 2024
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Oral Administration of AJH-2947 in Healthy Korean and/or Caucasian Adult Male Subjects
(clinicaltrials.gov)
- P1 | N=68 | Enrolling by invitation | Sponsor: JMackem Co., Ltd | Recruiting ➔ Enrolling by invitation | Trial completion date: Apr 2025 ➔ Sep 2025
Enrollment status • Trial completion date • Diabetic Neuropathy • Neuralgia • Pain
1 to 1
Of
1
Go to page
1